Suzetrigine
Suzetrigine is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand name including JOURNAVX. Available dosage forms: tablet, film coated, powder.
Drug Details
- Generic Name
- Suzetrigine
- Brand Names
- JOURNAVX
- Application Number
- NDA219209
- Sponsor
- Vertex Pharmaceuticals Incorporated
- NDC Codes
- 5
- Dosage Forms
- TABLET, FILM COATED, POWDER
- Routes
- ORAL
- Active Ingredients
- SUZETRIGINE
Indications and Usage
1 INDICATIONS AND USAGE JOURNAVX is indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults. JOURNAVX is a sodium channel blocker indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults. ( 1 )